This is a working overview of salvage pathway, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-09-01 and is reviewed periodically as new material appears.
Nicotinamide mononucleotide, commonly abbreviated NMN, is a naturally occurring nucleotide. Its structure consists of a nicotinamide ring attached to a ribose sugar that carries a phosphate group. The molecular formula is C11H15N2O8P, and the molar mass is about 334.22 grams per mole. In cells, NMN is an intermediate in the salvage pathway that recycles nicotinamide to maintain NAD+ levels. It is not the same compound as NAD+, although it is a direct precursor in one enzymatic step.
Inside cells, the enzyme nicotinamide phosphoribosyltransferase, or NAMPT, converts nicotinamide and a ribose-phosphate donor into NMN. A second enzyme, NMN adenylyltransferase, then converts NMN into NAD+. NAD+ participates in redox reactions and serves as a substrate for signaling enzymes such as sirtuins, PARPs, and CD38. Because NAD+ levels tend to decline with age in many organisms, NMN has drawn interest as a possible way to influence that decline. Whether oral NMN reliably raises NAD+ in human tissues, and whether any such change modifies disease risk, remain open research questions.
NAD+ serves as a coenzyme in redox reactions and as a substrate for enzymes involved in DNA repair and cellular signaling. In the salvage pathway, nicotinamide is converted to NMN by the enzyme NAMPT. NMN is then converted to NAD+ by NMNAT enzymes. A separate route links nicotinamide riboside to NMN through phosphorylation. These pathways maintain NAD+ levels, which can decline with age or metabolic stress in some tissues. The relative contribution of circulating NMN to tissue NAD+ remains an active area of study.
Research on NMN includes cell studies, animal experiments, and a growing number of human trials. Many early findings come from mice, where changes in NAD+ levels and metabolic markers have been reported. Human data are more limited, and questions remain about effective routes of administration, tissue distribution, and long-term effects. Some trials measure NAD+ in blood or tissue, while others assess physical function or metabolic outcomes. Regulatory status differs between countries, and NMN is not universally approved as a dietary supplement or therapeutic agent.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C11H15N2O8P | Identifies the atoms in the nucleotide |
| Molar mass | 334.22 g/mol | Calculated from the molecular formula |
| Appearance | White to off-white powder | Typical for purified solid material |
| Solubility | Water-soluble | Polar nucleotide; less soluble in nonpolar solvents |
| Common synonyms | Nicotinamide mononucleotide; beta-NMN | beta-NMN refers to the common anomeric form |
Research interest in NMN increased after animal studies reported that oral or injected NMN can raise NAD+ levels in some tissues. How NMN is absorbed and distributed in humans is not fully established. Some evidence suggests extracellular NMN may be dephosphorylated to nicotinamide riboside before cellular uptake, while other studies propose specific transport routes. Direct human data on these mechanisms remain limited. Regulatory status also varies: in some countries NMN is treated as a dietary supplement, while elsewhere it is restricted or requires approval, and these differences affect labeling, sale, and research.
Nicotinamide mononucleotide, commonly abbreviated NMN, is a naturally occurring nucleotide found in the cells of many organisms. Its structure consists of a nicotinamide group linked to a ribose sugar that carries a phosphate group. NMN is an intermediate in the biosynthesis of nicotinamide adenine dinucleotide, or NAD+, a coenzyme involved in many metabolic reactions. The abbreviation usually refers to the beta anomer, though related forms can exist. In scientific literature, NMN is distinct from nicotinamide riboside, another NAD+ precursor.
In the NAD+ salvage pathway, the enzyme NAMPT converts nicotinamide and a phosphate-donor molecule into NMN. A second enzyme, NMNAT, then converts NMN into NAD+. Nicotinamide riboside can also enter this route after being converted to NMN by nicotinamide riboside kinases. Because NMN sits at a junction between precursor uptake and NAD+ formation, its cellular concentration is tightly linked to enzyme activity and tissue type. NAD+ participates in redox reactions, signaling, and DNA repair, and its levels decline with age in some animal models, though human evidence remains more limited and context-dependent.
Research on NMN has focused on aging, metabolic regulation, exercise capacity, and insulin sensitivity, but findings are preliminary. Many human trials are small, short in duration, and use different endpoints, which complicates comparison across studies. No national regulator has approved NMN as a therapeutic drug for any indication. In some countries it is sold as a supplement or research chemical, while other jurisdictions have questioned its status under food or supplement laws. Claims about extending human lifespan or reversing aging are not supported by established clinical evidence.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in the cells of many organisms, including bacteria, plants, and mammals. Its structure consists of a nicotinamide ring attached to a ribose-phosphate group. NMN functions as an intermediate in the NAD+ salvage pathway, a recycling route that regenerates nicotinamide adenine dinucleotide. The enzyme nicotinamide phosphoribosyltransferase produces NMN from nicotinamide and phosphoribosyl pyrophosphate. A second enzyme, NMN adenylyltransferase, then converts NMN into NAD+.
The Rockefeller Foundation continued funding German eugenics research even after it was clear that it was being used to rationalize discrimination against Jewish people and other groups, after the Nuremberg laws in 1935. In 1936, Rockefeller fulfilled pledges of $655,000 to Kaiser Wilhelm Institute, even though several distinguished Jewish scientists had been dropped from the institute at the time. The Rockefeller Foundation did not alert the world about the racist implications of Nazi ideology, but furthered and funded eugenic research through the 1930s. Even into the 1950s, Rockefeller continued to provide some funding for research borne out of German eugenics. The foundation also funded the relocation of scholars threatened by the Nazis to America in the 1930s, known as the Refugee Scholar Program and the Emergency Committee in Aid of Displaced Foreign Scholars. Some of the notable figures relocated or saved, among a total of 303 scholars, were Thomas Mann, Claude Lévi-Strauss and Leó Szilárd. The foundation helped The New School provide a haven for scholars threatened by the Nazis.
Glossary of cellular and molecular biology (0–L) lists terms beginning with numbers and those beginning with the letters A through L. Glossary of cellular and molecular biology (M–Z) (this page) lists terms beginning with the letters M through Z. This glossary is intended as introductory material for novices (for more specific and technical detail, see the article corresponding to each term). It has been designed as a companion to Glossary of genetics and evolutionary biology, which contains many overlapping and related terms; other related glossaries include Glossary of virology and Glossary of chemistry.
== Occupational exposure == Occupational exposure to PFAS occurs in numerous industries due to the widespread use of the chemicals in products and as an element of industrial process streams. People who are exposed to PFAS through their jobs typically have higher blood concentrations of PFAS than the general population due to their elevated risk for accidental ingestion, inhalation exposure, and skin contact of PFAS. Occupational exposure can occur both during production of PFAS at fluorochemical facilities and in other industries that utilize these chemicals in their processes and products.
Analysis of potential molecules that could form the first hypercycles in nature prompted the idea of coupling an information carrier function with enzymatic properties. At the time of the hypercycle theory formulation, enzymatic properties were attributed only to proteins, while nucleic acids were recognized only as carriers of information. This led to the formulation of a more complex model of a hypercycle with translation. The proposed model consists of a number of nucleotide sequences I (I stands for intermediate) and the same number of polypeptide chains E (E stands for enzyme). Sequences I have a limited chain length and carry the information necessary to build catalytic chains E. The sequence Ii provides the matrix to reproduce itself and a matrix to build the protein Ei. The protein Ei gives the catalytic support to build the next sequence in the cycle, Ii+1. The self-replicating sequences I form a cycle consisting of positive and negative strands that periodically reproduce themselves. Therefore, many cycles of the +/− nucleotide collectives are linked together by the second-order cycle of enzymatic properties of E, forming a catalytic hypercycle. Without the secondary loop provided by catalysis, I chains would compete and select against each other instead of cooperating. The reproduction is possible thanks to translation and polymerization functions encoded in I chains.
Sources: en.wikipedia.org
There are many challenges surrounding human remains accessioned by museums, including legal complications involved in dealing with human remains, involvement of living relatives or tribes, and potential repatriation and issues such as the Native American Graves Protection and Repatriation Act of 1990 (NAGPRA). NAGPRA requires any federal or federally-funded institution, with the exception of the Smithsonian Institution, to submit full inventories of their Native American funerary and sacred objects and human remains and to repatriate these objects to their tribe of origin should a request be made to do so. Should a museum possess human remains which have a direct living relative or group (Native American or otherwise), it is their ethical obligation to involve these individuals in the care and treatment of the remains. Acquisition of human remains by museums can happen in a number of ways, some of which are considered to be unethical today. Many museums have human remains in their collections which have been there for over a hundred years, in which case they may likely have been acquired in ethically or morally unsound ways. This has led to growing concerns that the display of human remains has become depersonalised, by continuing to keep them in collections. Most institutions and museum associations have their own policies on the acquisition of human remains. Some guidelines for the care of human remains including acceptable means of acquisition can be found below.
Newsom supports a series of tentative water-sharing agreements that would bring an end to the dispute between farmers, cities, fishers, and environmentalists over how much water should be left in the state's two most important rivers, the Sacramento and San Joaquin, which flow into the Delta.
==== Cell cycle regulation ==== Cyclins are a group of proteins that activate kinases involved in cell division. The degradation of cyclins is the key step that governs the exit from mitosis and progress into the next cell cycle. Cyclins accumulate in the course the cell cycle, then abruptly disappear just before the anaphase of mitosis. The cyclins are removed via a ubiquitin-mediated proteolytic pathway.
==== Wittig-Still rearrangement ==== The 2,3-Wittig rearrangement is a useful carbon-carbon bond forming reaction that transforms an allyl ether into a homoallylic alcohol. However, a significant limitation of this reaction is the difficulty in forming the alkoxy-substituted carbanion which initiates the 2,3-sigmatropic rearrangement. Traditionally, this required the use of a strong base and the presence of a stabilizing group to enable deprotonation of the ether substrate. In 1978, Still dramatically increased the scope of the 2,3-Wittig rearrangement by introducing an organotin-substituted ether as a precursor to the alkoxy-substituted carbanion. In this procedure, transmetalation of the organotin group can be achieved chemoselectively at low temperature using n-butyllithium to form an alpha-lithiated ether that undergoes the desired 2,3-sigmatropic rearrangement. This variation of the traditional 2,3-Wittig reaction is known as the Wittig-Still rearrangement.
A well studied complex is tris(glycinato)cobalt(III). It is produced by the reaction of glycine with sodium tris(carbonato)cobalt(III). Similar synthetic methods apply to the preparation of tris(chelates) of other amino acids. Commonly amino acid complexes are prepared by ligand displacement reactions of metal aquo complexes and the conjugate bases of amino acids:
Sources: en.wikipedia.org
=== North Korea === The Potemkin village of Kijŏng-dong, which was constructed to convey an image of North Korea as prosperity, and to encourage South Korean soldiers to defect, has been cited as an example of architectural propaganda by architect Richard Buday.
Because reporter genes such as lacZ, GFP, and luciferase are widely used in standardized plasmid constructs for gene expression studies, well-characterized reporter vectors are preserved as reference materials in public biological resource centres and non-profit repositories such as BCCM/GeneCorner and Addgene, supporting reproducibility in molecular biology research.
== Biomolecular condensates in plants == Biomolecular condensates can play other roles in plants besides the compartmentalization of biochemical processes. They can integrate environmental cues and modulate plant development in response, influencing processes like floral transition. They achieve this by sequestering interacting components, enhancing dwell time, and interacting with cytoplasmic properties in response to environmental changes. They have shown to be involved also in autophagy, RNA silencing, and plant immunity. NAtural Deep Eutectic Solvents (NADES) are mixtures of natural compounds such as amino acids, sugars, choline, and organic acids that can solubilize high amounts of natural products. NADES are hypothesized to be the third liquid phase in plants, due to their presence in plant cells together with their ability to improve and stabilise enzymatic reactions, as well as enhance extraction and dissolution of natural products. They are speculated to facilitate the formation of phase-separated inclusions, aiding in the storage and transport of specific metabolites such as anthocyanins, dhurrin, and vanillin.
A eukaryotic initiation factor eIF3 plays an important role in translational initiation. It has a complex structure, composed of 13 subunits. It helps to create the 43S pre-initiation complex, composed of the small 40S subunit attached to other initiation factors. It also helps to create the 48S pre-initiation complex, consisting of the 43S complex with the mRNA. The eIF3 factor can also be used post-translation in order to separate the ribosomal complex and keep the small and large subunits apart. The initiation factor interacts with the eIF1 and eIF5 factors used for scanning and selection of the start codons. This can create changes in the selection of the factors, binding to different codons. Another important eukaryotic initiation factor, eIF2, binds the tRNA containing methionine to the P site of the small ribosome. The P site is where the tRNA carrying an amino acid forms a peptide bond with the incoming amino acids and carries the peptide chain. The factor consists of an alpha, beta, and gamma subunit. The eIF2 gamma subunit is characterized by a GTP-binding domain and beta-barrel folds. It binds to the tRNA through GTP. Once the initiation factor helps the tRNA bind, the GTP hydrolyzes and is released the eIF2. The eIF2 beta subunit is identified by its Zn-finger. The eIF2 alpha subunit is characterized by an OB-fold domain and two beta strands. This subunit helps to regulate translation, as it becomes phosphorylated to inhibit protein synthesis.
Some experts have argued that it is too early to regulate AI, expressing concerns that regulations will hamper innovation and it would be foolish to "rush to regulate in ignorance". Others, such as business magnate Elon Musk, call for pre-emptive action to mitigate catastrophic risks. In September 2026, Musk proposed that leading AI companies allow competitors to test their models before public release, arguing the independent testing by rival companies could identify safety concerns that might be missed through internal evaluations. Outside of formal legislation, government agencies have put forward ethical and safety recommendations. In March 2021, the US National Security Commission on Artificial Intelligence reported that advances in AI may make it increasingly important to "assure that systems are aligned with goals and values, including safety, robustness and trustworthiness". Subsequently, the National Institute of Standards and Technology drafted a framework for managing AI Risk, which advises that when "catastrophic risks are present – development and deployment should cease in a safe manner until risks can be sufficiently managed". In September 2021, the People's Republic of China (PRC) published ethical guidelines for the use of AI in China, emphasizing that AI decisions should remain under human control and calling for accountability mechanisms.
Sources: en.wikipedia.org
NMN stands for nicotinamide mononucleotide. It is a nucleotide intermediate in the cellular pathway that produces NAD+, a coenzyme involved in energy metabolism and signaling. NMN is not the same compound as NAD+.
NMN is a direct precursor to NAD+ in the salvage pathway. The enzyme NMNAT converts NMN into NAD+ by adding an adenine nucleotide group. This relationship is why NMN is studied in the context of NAD+ decline.
Yes, NMN is produced naturally in cells as part of NAD+ recycling. It also appears in small and variable amounts in some foods. Its natural presence does not by itself establish that supplemental NMN has clinical benefits.
NMN is a naturally occurring nucleotide and an intermediate in NAD+ biosynthesis. It consists of nicotinamide attached to a ribose phosphate unit. Cells produce it through the salvage pathway.